(Co)-first Authored Publications
- Beltrán-Visiedo, M., Campbell, K.S. and L. Galluzzi. Phosphatidylserine exposure and cancer immune evasion. Cell Res, 2026 IN PRESS.
- Beltrán-Visiedo, M., Soler-Agesta, R., Sarosiek, K.A. et al. Regulation of inflammatory processes by caspases. Nat Rev Mol Cell Biol, 2025. 26(11): p. 884-901.
- Beltrán-Visiedo, M., Shulman, R. and L. Galluzzi. Selective CDK4 inhibition holds promise for breast cancer. Cell Res, 2025. 35(11): p. 790-791.
- Catanzaro, E., Beltrán-Visiedo, M., Galluzzi, L. and D. Krysko. Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors. Cell Mol Immunol, 2025. 22: p. 24–39.
- Beltrán-Visiedo, M., Balachandran, S. and L. Galluzzi. MRE11 mobilizes CGAS and drives ZBP1-dependent necroptosis. Cell Res, 2024. 34(7): p. 477-478.
- Beltrán-Visiedo, M., Serrano-Del Valle, A., Jiménez-Aldúan, N., et al. Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrow. Methods Cell Biol, 2024. 189: p. 189-206.
Abstracts Selected for Oral Presentation
1. Beltrán-Visiedo, M., Soler-Agesta, R., Guilbaud, E., et al. Mitochondrial involvement in the cytotoxicity and immunogenicity of radiation therapy in breast cancer. European Workshop on Cell Death (May 2025).
Abstracts Selected for Poster Presentation
1. Beltrán-Visiedo, M., Soler-Agesta, R., Guilbaud, E., et al. MOMP-dependent cytotoxicity and immunogenicity of radiation therapy in breast cancer. AACR IO (American Association for Cancer Research) (February, 2025).
2. Beltrán-Visiedo, M., Soler-Agesta, R., Guilbaud, E., et al. Mitochondrial involvement in the cytotoxicity and immunogenicity of radiation therapy. SITC (Society of Immunotherapy of Cancer) (November, 2024).
Fellowships
- Gobierno de Aragón (DGA) 2025/2027 Post-doctoral Odón de Buen Fellowship.
My Bibliography Link
https://www.ncbi.nlm.nih.gov/myncbi/manuel.beltran-visiedo.1/bibliography/public/